- Home
- NGNE vs KRNY Comparison
NGNE vs KRNY Comparison
Compare NGNE & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGNE
- KRNY
- Stock Information
- Founded
- NGNE 2003
- KRNY 1884
- Country
- NGNE United States
- KRNY United States
- Employees
- NGNE N/A
- KRNY N/A
- Industry
- NGNE Biotechnology: Pharmaceutical Preparations
- KRNY Savings Institutions
- Sector
- NGNE Health Care
- KRNY Finance
- Exchange
- NGNE Nasdaq
- KRNY Nasdaq
- Market Cap
- NGNE 471.1M
- KRNY 436.9M
- IPO Year
- NGNE N/A
- KRNY 2005
- Fundamental
- Price
- NGNE $15.59
- KRNY $8.19
- Analyst Decision
- NGNE Strong Buy
- KRNY Hold
- Analyst Count
- NGNE 6
- KRNY 1
- Target Price
- NGNE $60.80
- KRNY $7.00
- AVG Volume (30 Days)
- NGNE 539.5K
- KRNY 364.8K
- Earning Date
- NGNE 11-18-2024
- KRNY 10-24-2024
- Dividend Yield
- NGNE N/A
- KRNY 5.37%
- EPS Growth
- NGNE N/A
- KRNY N/A
- EPS
- NGNE N/A
- KRNY N/A
- Revenue
- NGNE $925,000.00
- KRNY $128,413,999.00
- Revenue This Year
- NGNE N/A
- KRNY N/A
- Revenue Next Year
- NGNE N/A
- KRNY $28.55
- P/E Ratio
- NGNE N/A
- KRNY N/A
- Revenue Growth
- NGNE N/A
- KRNY N/A
- 52 Week Low
- NGNE $12.49
- KRNY $5.28
- 52 Week High
- NGNE $74.49
- KRNY $9.46
- Technical
- Relative Strength Index (RSI)
- NGNE 26.51
- KRNY 62.26
- Support Level
- NGNE $35.60
- KRNY $7.95
- Resistance Level
- NGNE $43.24
- KRNY $8.59
- Average True Range (ATR)
- NGNE 6.30
- KRNY 0.29
- MACD
- NGNE -5.15
- KRNY 0.00
- Stochastic Oscillator
- NGNE 1.85
- KRNY 76.88
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. It is also heavily into secured and unsecured business and consumer loans. The bank's primary source of income is net interest income.